Results 1 to 10 of about 103,612 (260)

Data Curation can Improve the Prediction Accuracy of Metabolic Intrinsic Clearance. [PDF]

open access: yesMol Inform, 2019
AbstractA key consideration at the screening stages of drug discovery is in vitro metabolic stability, often measured in human liver microsomes. Computational prediction models can be built using a large quantity of experimental data available from public databases, but these databases typically contain data measured using various protocols in ...
Esaki T   +6 more
europepmc   +4 more sources

Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties. [PDF]

open access: yesPharm Res, 2019
To examine the interlaboratory variability in CLint values generated with human hepatocytes and determine trends in variability and clearance prediction accuracy using physicochemical and pharmacokinetic parameters.Data for 50 compounds from 14 papers were compiled with physicochemical and pharmacokinetic parameter values taken from various sources ...
Bowman CM, Benet LZ.
europepmc   +6 more sources

Beyond the Michaelis–Menten: Evaluation of a tQSSA‐Based IVIVE Approach for Predicting In Vivo Intrinsic Clearance From Hepatocyte Assays [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology
The classical Michaelis–Menten model, under the standard quasi‐steady‐state approximation (sQSSA), is widely used in in vitro‐in vivo extrapolation (IVIVE) studies using hepatocyte or human liver microsomal (HLM) assays to predict intrinsic hepatic ...
Ngoc‐Anh Thi Vu   +6 more
doaj   +2 more sources

Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase. [PDF]

open access: yesMol Pharm, 2013
Metabolism by aldehyde oxidase (AO) has been responsible for a number of drug failures in clinical trials. The main reason is the clearance values for drugs metabolized by AO are underestimated by allometric scaling from preclinical species. Furthermore, in vitro human data also underestimates clearance.
Jones JP, Korzekwa KR.
europepmc   +5 more sources

Evaluation of the Use of a Medium Cut‐Off Dialyser Theranova 400 for Severe Metaldehyde Intoxication in Three Dogs: Dialytic Clearance and Therapeutic Response [PDF]

open access: yesVeterinary Medicine and Science
Objective To describe the clinical utility and toxin removal kinetics of a commercially available medium cut‐off (MCO) haemodialyser as emergent treatment of severe metaldehyde intoxication in three dogs.
Maxime Rodary   +5 more
doaj   +2 more sources

Intrinsic mechanical vibrations as a missing dimension in amyloid-β clearance: a mechanochemical hypothesis for Alzheimer’s disease [PDF]

open access: yesFrontiers in Aging Neuroscience
Alzheimer’s disease is widely viewed as a disorder of disturbed amyloid-β (Aβ) homeostasis, yet it remains unclear why Aβ shifts from routine turnover to progressive retention and plaque growth in mid-life.
Xiaochen Lai
doaj   +2 more sources

Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening

open access: yesPharmaceutics, 2023
Alectinib, also known as Alecensa®, is prescribed for the therapeutic treatment of individuals diagnosed with metastatic non-small cell lung cancer (NSCLC) who have a specific genetic mutation referred to as anaplastic lymphoma kinase (ALK) positivity ...
Mohamed W. Attwa   +3 more
doaj   +1 more source

Effects of CYP2C19 variants on the metabolism of tapentadol in vitro [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): This study aims to evaluate the catalytic activities of 31 CYP2C19 alleles and their effects on the metabolism of tapentadol in vitro. Materials and Methods: Insect microsomes expressing the CYP2C19 alleles were incubated with 50–1250 μM ...
Ren-ai Xu   +5 more
doaj   +1 more source

Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method

open access: yesMolecules, 2023
Selpercatinib (SLP; brand name Retevmo®) is a selective and potent RE arranged during transfection (RET) inhibitor. On 21 September 2022, the FDA granted regular approval to SLP (Retevmo, Eli Lilly, and Company).
Mohamed W. Attwa   +4 more
doaj   +1 more source

Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation

open access: yesMolecules, 2023
Sapitinib (AZD8931, SPT) is a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR) family (pan-erbB). In multiple tumor cell lines, STP has been shown to be a much more potent inhibitor of EGF-driven cellular proliferation than ...
Mohamed W. Attwa   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy